167 related articles for article (PubMed ID: 35330799)
1. Evaluation of [
Niu M; Qin J; Wang L; He Y; Tian C; Chen Y; Huang P; Peng Z
Mol Imaging; 2022; 2022():2679260. PubMed ID: 35330799
[TBL] [Abstract][Full Text] [Related]
2. [
Jiang H; DeGrado TR
Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
Jiang H; Bansal A; Pandey MK; Peng KW; Suksanpaisan L; Russell SJ; DeGrado TR
J Nucl Med; 2016 Sep; 57(9):1454-9. PubMed ID: 27103021
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter.
Jauregui-Osoro M; Sunassee K; Weeks AJ; Berry DJ; Paul RL; Cleij M; Banga JP; O'Doherty MJ; Marsden PK; Clarke SE; Ballinger JR; Szanda I; Cheng SY; Blower PJ
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2108-16. PubMed ID: 20577737
[TBL] [Abstract][Full Text] [Related]
5. Tracking dendritic cell migration into lymph nodes by using a novel PET probe
Lee SB; Lee HW; Lee H; Jeon YH; Lee SW; Ahn BC; Lee J; Jeong SY
EJNMMI Res; 2017 Dec; 7(1):32. PubMed ID: 28378292
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of
Jiang H; Bansal A; Goyal R; Peng KW; Russell SJ; DeGrado TR
Bioorg Med Chem; 2018 Jan; 26(1):225-231. PubMed ID: 29198608
[TBL] [Abstract][Full Text] [Related]
7.
O'Doherty J; Jauregui-Osoro M; Brothwood T; Szyszko T; Marsden PK; O'Doherty MJ; Cook GJR; Blower PJ; Lewington V
J Nucl Med; 2017 Oct; 58(10):1666-1671. PubMed ID: 28385795
[TBL] [Abstract][Full Text] [Related]
8. Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter.
Lehmacher M; Stolzenburg A; Samnick S
Curr Cancer Drug Targets; 2020; 20(2):146-155. PubMed ID: 32056515
[TBL] [Abstract][Full Text] [Related]
9. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.
Sakemura R; Bansal A; Siegler EL; Hefazi M; Yang N; Khadka RH; Newsom AN; Hansen MJ; Cox MJ; Manriquez Roman C; Schick KJ; Can I; Tapper EE; Nevala WK; Adada MM; Bezerra ED; Kankeu Fonkoua LA; Horvei P; Ruff MW; Parikh SA; Pandey MK; DeGrado TR; Suksanpaisan L; Kay NE; Peng KW; Russell SJ; Kenderian SS
Cancer Immunol Res; 2021 Sep; 9(9):1035-1046. PubMed ID: 34244299
[TBL] [Abstract][Full Text] [Related]
10. Safety, pharmacokinetics, metabolism and radiation dosimetry of
Jiang H; Schmit NR; Koenen AR; Bansal A; Pandey MK; Glynn RB; Kemp BJ; Delaney KL; Dispenzieri A; Bakkum-Gamez JN; Peng KW; Russell SJ; Gunderson TM; Lowe VJ; DeGrado TR
EJNMMI Res; 2017 Oct; 7(1):90. PubMed ID: 29080017
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS.
Weeks AJ; Jauregui-Osoro M; Cleij M; Blower JE; Ballinger JR; Blower PJ
Nucl Med Commun; 2011 Feb; 32(2):98-105. PubMed ID: 21085047
[TBL] [Abstract][Full Text] [Related]
12. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
Samnick S; Al-Momani E; Schmid JS; Mottok A; Buck AK; Lapa C
Clin Nucl Med; 2018 Mar; 43(3):162-167. PubMed ID: 29356744
[TBL] [Abstract][Full Text] [Related]
13. [
Diocou S; Volpe A; Jauregui-Osoro M; Boudjemeline M; Chuamsaamarkkee K; Man F; Blower PJ; Ng T; Mullen GED; Fruhwirth GO
Sci Rep; 2017 Apr; 7(1):946. PubMed ID: 28424464
[TBL] [Abstract][Full Text] [Related]
14. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Kitzberger C; Spellerberg R; Morath V; Schwenk N; Schmohl KA; Schug C; Urnauer S; Tutter M; Eiber M; Schilling F; Weber WA; Ziegler S; Bartenstein P; Wagner E; Nelson PJ; Spitzweg C
EJNMMI Res; 2022 May; 12(1):25. PubMed ID: 35503582
[TBL] [Abstract][Full Text] [Related]
15. High molar activity [
Soloviev D; Dzien P; Mackintosh A; Malviya G; Brown G; Lewis D
EJNMMI Radiopharm Chem; 2022 Dec; 7(1):32. PubMed ID: 36512196
[TBL] [Abstract][Full Text] [Related]
16. Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.
Petrich T; Quintanilla-Martinez L; Korkmaz Z; Samson E; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Clin Cancer Res; 2006 Feb; 12(4):1342-8. PubMed ID: 16489092
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
18. Improved Noninvasive In Vivo Tracking of AAV-9 Gene Therapy Using the Perchlorate-Resistant Sodium Iodide Symporter from Minke Whale.
Concilio SC; Suksanpaisan L; Pham L; Peng KW; Russell SJ
Mol Ther; 2021 Jan; 29(1):236-243. PubMed ID: 33038323
[TBL] [Abstract][Full Text] [Related]
19. A new antiviral hypothesis and radioactive iodine therapy to other cancers, such as breast cancer, lung cancer, and glioblastoma multiforme (GBM)?
Czarnywojtek A; Gut P; Borowska M; Sawicka-Gutaj N; Caputa P; Kos-Kudła B; Ruchała M; Dworacka M
Endokrynol Pol; 2023; 74(6):. PubMed ID: 38159203
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
